Searchable abstracts of presentations at key conferences in endocrinology

ea0021p233 | Growth and development | SFEBES2009

A novel dominant-negative Glial Cells Missing B (GCMB) mutation (Asn502His) is associated with autosomal dominant hypoparathyroidism and results in reduced transactivation activity

Bowl Michael , Mirzcuk Samantha , Fratter Carl , Cranston Treena , Allgrove Jeremy , Brain Caroline , Nesbit Andrew , Thakker Rajesh

Glial cells missing B (GCMB), which is the mammalian homologue of the Drosophila GCM gene, encodes a 506 amino acid parathyroid-specific transcription factor that contains: a DNA-binding domain (residues 21–174); a predicted nuclear localization signal (residues 176–193); an inhibitory domain (residues 258–347); and two transactivation domains (residues 174–263, and residues 428–506). To date only two different GCMB m...

ea0028oc1.2 | Young Endocrinologists prize session | SFEBES2012

Structure-function analysis of calcium-sensing receptor (CaSR) mutations reveal clustering at calcium binding sites of the extracellular bilobed venus flytrap domain

Hannan Fadil , Nesbit M Andrew , Zhang Chen , Cranston Treena , Christie Paul , Fratter Carl , Brown Edward , Yang Jenny , Thakker Rajesh

The calcium-sensing receptor (CaSR) is a G protein-coupled receptor with an extracellular bilobed venus flytrap domain (VFTD) predicted to contain five calcium-binding sites. The major site for calcium-binding is comprised of amino acid residues that line the cleft between the two lobes of the VFTD. We investigated the structure-function relationships of VFTD CaSR mutations identified in patients with familial hypocalciuric hypercalcaemia (FHH), neonatal severe primary hyperpa...